In regard to cancer, tumorigenesis is promoted by IL-17 via the combination of releasing myeloid-derived suppressor cells (MDSCs) to inhibit immune system, as well as stimulating pro-inflammatory cytokines to maintain an inflammatory environment. This evidence concerns the gene IL17A and cancer.